

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.62842566 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 4.95989374 |
| 3 | regulation of vitamin metabolic process (GO:0030656) | 4.64467049 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.56160229 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36949632 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32484158 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29710243 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29710243 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 4.16070072 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 4.16070072 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.16070072 |
| 12 | response to peptidoglycan (GO:0032494) | 4.07252435 |
| 13 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.06384654 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.02585764 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.02236344 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 3.95797368 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.95797368 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.95019582 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.93763298 |
| 20 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.93615692 |
| 21 | cellular response to type I interferon (GO:0071357) | 3.91979589 |
| 22 | type I interferon signaling pathway (GO:0060337) | 3.91979589 |
| 23 | response to type I interferon (GO:0034340) | 3.90590748 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.88586037 |
| 25 | regulation of chemokine biosynthetic process (GO:0045073) | 3.84044427 |
| 26 | positive regulation of type 2 immune response (GO:0002830) | 3.81798328 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 3.81715753 |
| 28 | defense response to protozoan (GO:0042832) | 3.77693210 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77551853 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.76655009 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.76655009 |
| 32 | phospholipid efflux (GO:0033700) | 3.70066752 |
| 33 | regulation of podosome assembly (GO:0071801) | 3.69998335 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 3.69360163 |
| 35 | response to protozoan (GO:0001562) | 3.66891620 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.62901732 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.62806161 |
| 38 | regulation of RIG-I signaling pathway (GO:0039535) | 3.59805594 |
| 39 | response to interferon-alpha (GO:0035455) | 3.58214102 |
| 40 | positive regulation of interferon-alpha production (GO:0032727) | 3.52360374 |
| 41 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.49594183 |
| 42 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46068842 |
| 43 | positive regulation of heat generation (GO:0031652) | 3.45545119 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.44404652 |
| 45 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.42596495 |
| 46 | NAD biosynthetic process (GO:0009435) | 3.42577187 |
| 47 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.41886776 |
| 48 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.41525309 |
| 49 | T-helper 1 type immune response (GO:0042088) | 3.41480864 |
| 50 | regulation of T-helper cell differentiation (GO:0045622) | 3.38800291 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.38701348 |
| 52 | regulation of activation of Janus kinase activity (GO:0010533) | 3.37287346 |
| 53 | urea cycle (GO:0000050) | 3.36661846 |
| 54 | urea metabolic process (GO:0019627) | 3.36661846 |
| 55 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.35196128 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 3.34865950 |
| 57 | regulation of interleukin-12 production (GO:0032655) | 3.34740555 |
| 58 | regulation of mononuclear cell migration (GO:0071675) | 3.34380343 |
| 59 | regulation of fever generation (GO:0031620) | 3.33733952 |
| 60 | complement activation, alternative pathway (GO:0006957) | 3.33451256 |
| 61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.33329173 |
| 62 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.32148286 |
| 63 | bile acid biosynthetic process (GO:0006699) | 3.31741199 |
| 64 | alpha-linolenic acid metabolic process (GO:0036109) | 3.31342882 |
| 65 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.30709928 |
| 66 | protein carboxylation (GO:0018214) | 3.30709928 |
| 67 | regulation of immunoglobulin secretion (GO:0051023) | 3.30279689 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.29963335 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 3.29376293 |
| 70 | positive regulation of defense response to virus by host (GO:0002230) | 3.29021817 |
| 71 | protein-lipid complex remodeling (GO:0034368) | 3.28611361 |
| 72 | macromolecular complex remodeling (GO:0034367) | 3.28611361 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.28611361 |
| 74 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.24890146 |
| 75 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.24731497 |
| 76 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24567832 |
| 77 | reverse cholesterol transport (GO:0043691) | 3.22766784 |
| 78 | myeloid dendritic cell activation (GO:0001773) | 3.20238219 |
| 79 | germinal center formation (GO:0002467) | 3.19312020 |
| 80 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.18800485 |
| 81 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.16880314 |
| 82 | regulation of growth of symbiont in host (GO:0044126) | 3.16880314 |
| 83 | negative regulation of growth of symbiont in host (GO:0044130) | 3.16880314 |
| 84 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.16880314 |
| 85 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.16835438 |
| 86 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.16835438 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14920794 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 3.13983795 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.13248511 |
| 90 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.13180098 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 3.10748128 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.09918906 |
| 93 | positive regulation of humoral immune response (GO:0002922) | 3.09487080 |
| 94 | nitrogen cycle metabolic process (GO:0071941) | 3.09187479 |
| 95 | dendritic cell differentiation (GO:0097028) | 3.08633349 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.07689711 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 3.07653893 |
| 98 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.07611974 |
| 99 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.07105060 |
| 100 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05779113 |
| 101 | valine metabolic process (GO:0006573) | 3.04977254 |
| 102 | cellular response to interferon-gamma (GO:0071346) | 3.04884002 |
| 103 | cellular response to exogenous dsRNA (GO:0071360) | 3.04436022 |
| 104 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.04303029 |
| 105 | glyoxylate metabolic process (GO:0046487) | 3.04005010 |
| 106 | response to interferon-beta (GO:0035456) | 3.02169731 |
| 107 | regulation of type 2 immune response (GO:0002828) | 2.99556252 |
| 108 | response to interferon-gamma (GO:0034341) | 2.96329382 |
| 109 | regulation of protein activation cascade (GO:2000257) | 2.96178489 |
| 110 | cellular response to lipopolysaccharide (GO:0071222) | 2.95817301 |
| 111 | interferon-gamma secretion (GO:0072643) | 2.95499590 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93702686 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.92945833 |
| 114 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.92010142 |
| 115 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.91965511 |
| 116 | amine catabolic process (GO:0009310) | 2.91837243 |
| 117 | cellular biogenic amine catabolic process (GO:0042402) | 2.91837243 |
| 118 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.91066356 |
| 119 | * positive regulation of natural killer cell differentiation (GO:0032825) | 2.90924980 |
| 120 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.90633275 |
| 121 | cellular response to interferon-beta (GO:0035458) | 2.90563062 |
| 122 | cholesterol efflux (GO:0033344) | 2.90106649 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.89790101 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 2.89316630 |
| 125 | sulfur amino acid catabolic process (GO:0000098) | 2.88492399 |
| 126 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88069377 |
| 127 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88069377 |
| 128 | modulation by symbiont of host immune response (GO:0052553) | 2.88069377 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88069377 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.88069377 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88069377 |
| 132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87940968 |
| 133 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.86934139 |
| 134 | cellular response to molecule of bacterial origin (GO:0071219) | 2.86263104 |
| 135 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.86237159 |
| 136 | acute-phase response (GO:0006953) | 2.85169451 |
| 137 | regulation of T-helper 1 type immune response (GO:0002825) | 2.85087482 |
| 138 | T cell migration (GO:0072678) | 2.85086960 |
| 139 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84823907 |
| 140 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.83044455 |
| 141 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.83040377 |
| 142 | positive regulation of interferon-beta production (GO:0032728) | 2.82033498 |
| 143 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82013265 |
| 144 | negative regulation of cell killing (GO:0031342) | 2.82013265 |
| 145 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81574894 |
| 146 | cellular response to interferon-alpha (GO:0035457) | 2.80760195 |
| 147 | monocyte chemotaxis (GO:0002548) | 2.80578553 |
| 148 | B cell mediated immunity (GO:0019724) | 2.80308820 |
| 149 | regulation of response to interferon-gamma (GO:0060330) | 2.80163146 |
| 150 | aromatic amino acid family metabolic process (GO:0009072) | 2.79809824 |
| 151 | regulation of fibrinolysis (GO:0051917) | 2.79174683 |
| 152 | mature B cell differentiation involved in immune response (GO:0002313) | 2.77780170 |
| 153 | amino-acid betaine metabolic process (GO:0006577) | 2.77274284 |
| 154 | negative regulation of lipid storage (GO:0010888) | 2.77114444 |
| 155 | negative regulation of cholesterol transport (GO:0032375) | 2.77052588 |
| 156 | negative regulation of sterol transport (GO:0032372) | 2.77052588 |
| 157 | homocysteine metabolic process (GO:0050667) | 2.76907318 |
| 158 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.75475807 |
| 159 | negative regulation of fibrinolysis (GO:0051918) | 2.74890878 |
| 160 | bile acid metabolic process (GO:0008206) | 2.74826843 |
| 161 | regulation of complement activation (GO:0030449) | 2.74800910 |
| 162 | positive regulation of lipid catabolic process (GO:0050996) | 2.74169425 |
| 163 | triglyceride homeostasis (GO:0070328) | 2.71360549 |
| 164 | acylglycerol homeostasis (GO:0055090) | 2.71360549 |
| 165 | myeloid dendritic cell differentiation (GO:0043011) | 2.68604617 |
| 166 | positive regulation of interleukin-12 production (GO:0032735) | 2.68314347 |
| 167 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.67631299 |
| 168 | natural killer cell mediated immunity (GO:0002228) | 2.67631299 |
| 169 | opsonization (GO:0008228) | 2.66966936 |
| 170 | plasma lipoprotein particle organization (GO:0071827) | 2.64963081 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63939987 |
| 172 | cysteine metabolic process (GO:0006534) | 2.63475496 |
| 173 | regulation of cholesterol storage (GO:0010885) | 2.62547417 |
| 174 | plasma lipoprotein particle assembly (GO:0034377) | 2.55983694 |
| 175 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.55051986 |
| 176 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.54959179 |
| 177 | 2-oxoglutarate metabolic process (GO:0006103) | 2.52931508 |
| 178 | benzene-containing compound metabolic process (GO:0042537) | 2.52646059 |
| 179 | cofactor catabolic process (GO:0051187) | 2.52250005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69828240 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.41090120 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.95280414 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64139271 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.50670223 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.39445107 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.21877787 |
| 8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.09601918 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.04224610 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66540420 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19791465 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.09781849 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.06943616 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02056499 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72871954 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63916252 |
| 17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.56968181 |
| 18 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.52010394 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43854948 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29980527 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23482262 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.22885955 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.15463717 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.12387140 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07938656 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03174333 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96527409 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88431295 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77688994 |
| 30 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74143540 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73411614 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72539137 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70122709 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68976836 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68759521 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44395658 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42669717 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33989144 |
| 39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26961056 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24832641 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23625985 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22212187 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21041827 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20334245 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18755017 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.17962674 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.17330526 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17232547 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13323318 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12057723 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11534410 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10838445 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10793511 |
| 54 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10129874 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08330603 |
| 56 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07176817 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06205851 |
| 58 | * MYB_26560356_Chip-Seq_TH1_Human | 1.05986063 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05609097 |
| 60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.05590344 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03047946 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02583290 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02568674 |
| 64 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01893417 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01256462 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00818249 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00035037 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99523295 |
| 69 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99063904 |
| 70 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.96502062 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96139618 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95999350 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93304932 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93075810 |
| 75 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92877774 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92652681 |
| 77 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92405256 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92158239 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91809273 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90847996 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89534689 |
| 82 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88401869 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88135806 |
| 84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88125599 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 0.87699317 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87453499 |
| 87 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.85415683 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85341334 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85231019 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85108447 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84024264 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83555419 |
| 93 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82886214 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82556878 |
| 95 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.82376675 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81875331 |
| 97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81817861 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81268294 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.80538628 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80429463 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79943761 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.79611337 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77960088 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77777775 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77777775 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74289543 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.73771893 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73005861 |
| 109 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.71775381 |
| 110 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70449413 |
| 111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.68006928 |
| 112 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.66077321 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65919801 |
| 114 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.65783428 |
| 115 | SPI1_23127762_ChIP-Seq_K562_Human | 0.65698273 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.64694988 |
| 117 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.64661673 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.63642973 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63333420 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.62987618 |
| 121 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60980252 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.60537546 |
| 123 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60408298 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60026547 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.59664411 |
| 126 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.59315598 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58140585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.38444128 |
| 2 | MP0005360_urolithiasis | 3.87171650 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.61250207 |
| 4 | MP0005365_abnormal_bile_salt | 3.35729289 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.34418648 |
| 6 | MP0000685_abnormal_immune_system | 3.00227121 |
| 7 | MP0009785_altered_susceptibility_to | 2.98451599 |
| 8 | MP0002254_reproductive_system_inflammat | 2.87689573 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.75440714 |
| 10 | MP0003724_increased_susceptibility_to | 2.74062447 |
| 11 | MP0009840_abnormal_foam_cell | 2.63001852 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.57801784 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.54715580 |
| 14 | MP0003436_decreased_susceptibility_to | 2.53833080 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.41989665 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.33911213 |
| 17 | MP0004510_myositis | 2.20327499 |
| 18 | MP0005025_abnormal_response_to | 2.17767157 |
| 19 | MP0003252_abnormal_bile_duct | 2.17391589 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.11412530 |
| 21 | * MP0001790_abnormal_immune_system | 2.10848088 |
| 22 | * MP0005387_immune_system_phenotype | 2.10848088 |
| 23 | MP0005671_abnormal_response_to | 2.09415387 |
| 24 | MP0006082_CNS_inflammation | 2.07605408 |
| 25 | MP0009764_decreased_sensitivity_to | 2.05971134 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.95408330 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.92921753 |
| 28 | MP0002419_abnormal_innate_immunity | 1.88107203 |
| 29 | MP0001853_heart_inflammation | 1.87898799 |
| 30 | MP0001800_abnormal_humoral_immune | 1.82961557 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.82659814 |
| 32 | MP0003195_calcinosis | 1.77671676 |
| 33 | MP0005083_abnormal_biliary_tract | 1.70836175 |
| 34 | MP0002006_tumorigenesis | 1.69727179 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.69254416 |
| 36 | MP0008469_abnormal_protein_level | 1.68463966 |
| 37 | * MP0002723_abnormal_immune_serum | 1.67705658 |
| 38 | MP0009278_abnormal_bone_marrow | 1.67585681 |
| 39 | MP0008004_abnormal_stomach_pH | 1.66374432 |
| 40 | MP0005332_abnormal_amino_acid | 1.64415199 |
| 41 | MP0000609_abnormal_liver_physiology | 1.62698316 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.62090774 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.61996243 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.52515027 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.51040461 |
| 46 | MP0003186_abnormal_redox_activity | 1.48785418 |
| 47 | MP0004947_skin_inflammation | 1.42815027 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.40234407 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.39605070 |
| 50 | MP0005166_decreased_susceptibility_to | 1.39197539 |
| 51 | * MP0001819_abnormal_immune_cell | 1.36781996 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.36441435 |
| 53 | MP0006054_spinal_hemorrhage | 1.34928931 |
| 54 | MP0009763_increased_sensitivity_to | 1.33148830 |
| 55 | * MP0002420_abnormal_adaptive_immunity | 1.32959249 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.31035827 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.30784139 |
| 58 | MP0001346_abnormal_lacrimal_gland | 1.29823566 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.28949610 |
| 60 | MP0002163_abnormal_gland_morphology | 1.28644005 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.28105176 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27888419 |
| 63 | MP0005310_abnormal_salivary_gland | 1.26123350 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.22184527 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.21368975 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.17452248 |
| 67 | MP0001764_abnormal_homeostasis | 1.14339203 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.12863058 |
| 69 | MP0005164_abnormal_response_to | 1.11275142 |
| 70 | MP0001873_stomach_inflammation | 1.07250848 |
| 71 | * MP0000716_abnormal_immune_system | 1.07159862 |
| 72 | MP0002933_joint_inflammation | 1.05381617 |
| 73 | MP0002405_respiratory_system_inflammati | 1.04572806 |
| 74 | MP0005165_increased_susceptibility_to | 1.00427681 |
| 75 | MP0009643_abnormal_urine_homeostasis | 0.99604614 |
| 76 | MP0003075_altered_response_to | 0.98469286 |
| 77 | MP0001663_abnormal_digestive_system | 0.97739103 |
| 78 | MP0005670_abnormal_white_adipose | 0.97689226 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.97227958 |
| 80 | MP0005390_skeleton_phenotype | 0.96857207 |
| 81 | MP0003303_peritoneal_inflammation | 0.96433965 |
| 82 | MP0005451_abnormal_body_composition | 0.95373882 |
| 83 | MP0002971_abnormal_brown_adipose | 0.94473495 |
| 84 | MP0000604_amyloidosis | 0.93497017 |
| 85 | MP0004130_abnormal_muscle_cell | 0.92670209 |
| 86 | * MP0002398_abnormal_bone_marrow | 0.92515335 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.90978622 |
| 88 | MP0001542_abnormal_bone_strength | 0.90877044 |
| 89 | MP0003690_abnormal_glial_cell | 0.87544866 |
| 90 | MP0000598_abnormal_liver_morphology | 0.86757319 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.86001919 |
| 92 | MP0009697_abnormal_copulation | 0.85193235 |
| 93 | MP0003091_abnormal_cell_migration | 0.83404540 |
| 94 | * MP0002429_abnormal_blood_cell | 0.82914974 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.82674550 |
| 96 | MP0001545_abnormal_hematopoietic_system | 0.82674550 |
| 97 | MP0000343_altered_response_to | 0.79629712 |
| 98 | MP0005023_abnormal_wound_healing | 0.79507102 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.78726314 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.78445605 |
| 101 | MP0003705_abnormal_hypodermis_morpholog | 0.77654712 |
| 102 | MP0005535_abnormal_body_temperature | 0.76316276 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.74553881 |
| 104 | MP0001881_abnormal_mammary_gland | 0.74299498 |
| 105 | MP0009642_abnormal_blood_homeostasis | 0.74134915 |
| 106 | MP0008874_decreased_physiological_sensi | 0.73848798 |
| 107 | MP0003646_muscle_fatigue | 0.73529223 |
| 108 | MP0005647_abnormal_sex_gland | 0.73325797 |
| 109 | * MP0003763_abnormal_thymus_physiology | 0.73074152 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.71341683 |
| 111 | MP0009115_abnormal_fat_cell | 0.71034280 |
| 112 | * MP0002722_abnormal_immune_system | 0.70524170 |
| 113 | MP0005334_abnormal_fat_pad | 0.70188893 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.69470593 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.69012436 |
| 116 | MP0003448_altered_tumor_morphology | 0.69001870 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.68735454 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.68261186 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.67412922 |
| 120 | MP0000858_altered_metastatic_potential | 0.67074774 |
| 121 | MP0003866_abnormal_defecation | 0.66572225 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.66344632 |
| 123 | MP0000249_abnormal_blood_vessel | 0.65982016 |
| 124 | MP0004883_abnormal_blood_vessel | 0.64363326 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.63199599 |
| 126 | MP0003950_abnormal_plasma_membrane | 0.62466718 |
| 127 | MP0003795_abnormal_bone_structure | 0.61383513 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.61345344 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.60243762 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.60046338 |
| 131 | MP0005266_abnormal_metabolism | 0.59497085 |
| 132 | MP0005381_digestive/alimentary_phenotyp | 0.57947790 |
| 133 | MP0001851_eye_inflammation | 0.56862973 |
| 134 | MP0003045_fibrosis | 0.54888966 |
| 135 | MP0000703_abnormal_thymus_morphology | 0.54255837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.27275750 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.27275750 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.27275750 |
| 4 | Stomatitis (HP:0010280) | 4.44927555 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.36065184 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.26748592 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.18111364 |
| 8 | Xanthomatosis (HP:0000991) | 3.98253913 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96994052 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.96455783 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.90490139 |
| 12 | Increased IgM level (HP:0003496) | 3.77080723 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.75634228 |
| 14 | Joint hemorrhage (HP:0005261) | 3.74158234 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.69539094 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.65455856 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.61472328 |
| 18 | Complement deficiency (HP:0004431) | 3.49977047 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.45682653 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.44299555 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.41677296 |
| 22 | Myocardial infarction (HP:0001658) | 3.38234669 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.32913715 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.30353919 |
| 25 | Loss of speech (HP:0002371) | 3.29259825 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.25917065 |
| 27 | Gingival bleeding (HP:0000225) | 3.23224174 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21802113 |
| 29 | Gangrene (HP:0100758) | 3.21301515 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.17148050 |
| 31 | Hemoptysis (HP:0002105) | 3.14355909 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 3.11583058 |
| 33 | Myositis (HP:0100614) | 3.03005132 |
| 34 | T lymphocytopenia (HP:0005403) | 2.99769914 |
| 35 | Nuclear cataract (HP:0100018) | 2.97362850 |
| 36 | Orchitis (HP:0100796) | 2.96242928 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.96150723 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.91769437 |
| 39 | Epidermoid cyst (HP:0200040) | 2.90753730 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.89335589 |
| 41 | Hyperammonemia (HP:0001987) | 2.84922358 |
| 42 | Ketosis (HP:0001946) | 2.82845888 |
| 43 | Increased serum ferritin (HP:0003281) | 2.78841506 |
| 44 | Periodontitis (HP:0000704) | 2.78798739 |
| 45 | Disinhibition (HP:0000734) | 2.77135985 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 2.76330717 |
| 47 | Parakeratosis (HP:0001036) | 2.74214388 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73273528 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73273528 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73273528 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.72224528 |
| 52 | Optic neuritis (HP:0100653) | 2.72224528 |
| 53 | Hypolipoproteinemia (HP:0010981) | 2.69884541 |
| 54 | Vasculitis (HP:0002633) | 2.68858425 |
| 55 | Hydroxyprolinuria (HP:0003080) | 2.67944134 |
| 56 | Abnormality of proline metabolism (HP:0010907) | 2.67944134 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67435108 |
| 58 | Chronic otitis media (HP:0000389) | 2.67225518 |
| 59 | Abnormality of complement system (HP:0005339) | 2.66071731 |
| 60 | Recurrent skin infections (HP:0001581) | 2.65767087 |
| 61 | Spontaneous abortion (HP:0005268) | 2.65461873 |
| 62 | Joint swelling (HP:0001386) | 2.65329263 |
| 63 | Tetraparesis (HP:0002273) | 2.60722217 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.60335003 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.60142531 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.60102869 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60102869 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.59381490 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.58679299 |
| 70 | Meningitis (HP:0001287) | 2.55591465 |
| 71 | Encephalitis (HP:0002383) | 2.55544211 |
| 72 | Mitral stenosis (HP:0001718) | 2.54661676 |
| 73 | IgA deficiency (HP:0002720) | 2.54563243 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53446028 |
| 75 | Anorexia (HP:0002039) | 2.52968576 |
| 76 | Abnormality of macrophages (HP:0004311) | 2.52005634 |
| 77 | Hematochezia (HP:0002573) | 2.51905664 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.51290433 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.48857923 |
| 80 | Fat malabsorption (HP:0002630) | 2.48171995 |
| 81 | Hyperglycinuria (HP:0003108) | 2.46884052 |
| 82 | Thrombophlebitis (HP:0004418) | 2.46474810 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.46395697 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.43406304 |
| 85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39532809 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 2.38758140 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.38731400 |
| 88 | Esophageal varix (HP:0002040) | 2.36775458 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 2.36723358 |
| 90 | Polyneuropathy (HP:0001271) | 2.35942526 |
| 91 | Arterial thrombosis (HP:0004420) | 2.35599440 |
| 92 | Increased IgE level (HP:0003212) | 2.35270126 |
| 93 | Abnormality of the pericardium (HP:0001697) | 2.35243251 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34331125 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34298403 |
| 96 | Obstructive lung disease (HP:0006536) | 2.33946721 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33946721 |
| 98 | Axonal loss (HP:0003447) | 2.31337005 |
| 99 | Mediastinal lymphadenopathy (HP:0100721) | 2.31333929 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.30144902 |
| 101 | Mutism (HP:0002300) | 2.28455859 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.28081443 |
| 103 | Abnormality of B cell number (HP:0010975) | 2.27805924 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25777207 |
| 105 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25777207 |
| 106 | Recurrent bronchitis (HP:0002837) | 2.25582182 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 2.22053034 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22053034 |
| 109 | Epistaxis (HP:0000421) | 2.21694675 |
| 110 | Abnormality of glycine metabolism (HP:0010895) | 2.21406050 |
| 111 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21406050 |
| 112 | Vascular calcification (HP:0004934) | 2.21134052 |
| 113 | Basal ganglia calcification (HP:0002135) | 2.20364063 |
| 114 | Glomerulonephritis (HP:0000099) | 2.20232074 |
| 115 | Ketoacidosis (HP:0001993) | 2.20172810 |
| 116 | Hemorrhage of the eye (HP:0011885) | 2.19985345 |
| 117 | Recurrent viral infections (HP:0004429) | 2.19476354 |
| 118 | Malnutrition (HP:0004395) | 2.18554071 |
| 119 | Abnormality of nucleobase metabolism (HP:0010932) | 2.18228394 |
| 120 | Amyloidosis (HP:0011034) | 2.18003906 |
| 121 | Gingivitis (HP:0000230) | 2.17798946 |
| 122 | Hepatosplenomegaly (HP:0001433) | 2.16594071 |
| 123 | Leukocytosis (HP:0001974) | 2.16282955 |
| 124 | Urticaria (HP:0001025) | 2.16021861 |
| 125 | Gastrointestinal stroma tumor (HP:0100723) | 2.15420241 |
| 126 | Hyperbilirubinemia (HP:0002904) | 2.13482345 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11226412 |
| 128 | Petechiae (HP:0000967) | 2.10554306 |
| 129 | Pancreatitis (HP:0001733) | 2.10372581 |
| 130 | Hypertensive crisis (HP:0100735) | 2.10321021 |
| 131 | B lymphocytopenia (HP:0010976) | 2.10074518 |
| 132 | Nephritis (HP:0000123) | 2.09775661 |
| 133 | Thrombocytosis (HP:0001894) | 2.09431938 |
| 134 | Nasal polyposis (HP:0100582) | 2.09099871 |
| 135 | Abnormality of the nasal mucosa (HP:0000433) | 2.08805189 |
| 136 | Arthralgia (HP:0002829) | 2.07713465 |
| 137 | Abnormality of purine metabolism (HP:0004352) | 2.07576187 |
| 138 | Hypertriglyceridemia (HP:0002155) | 2.07006881 |
| 139 | Pulmonary embolism (HP:0002204) | 2.05931277 |
| 140 | Hypochromic anemia (HP:0001931) | 2.05702278 |
| 141 | Steatorrhea (HP:0002570) | 2.05658269 |
| 142 | Keratoconjunctivitis (HP:0001096) | 2.05571331 |
| 143 | Hyperglycinemia (HP:0002154) | 2.05530535 |
| 144 | Acne (HP:0001061) | 2.04602008 |
| 145 | Keratoconjunctivitis sicca (HP:0001097) | 2.04542043 |
| 146 | Interstitial pulmonary disease (HP:0006530) | 2.04269294 |
| 147 | Pulmonary infiltrates (HP:0002113) | 2.02350356 |
| 148 | Chronic diarrhea (HP:0002028) | 2.02215352 |
| 149 | Purpura (HP:0000979) | 2.02198574 |
| 150 | Nausea (HP:0002018) | 2.02166582 |
| 151 | Abnormality of the endocardium (HP:0004306) | 2.01144186 |
| 152 | Abnormality of T cells (HP:0002843) | 2.01031202 |
| 153 | Glomerulopathy (HP:0100820) | 2.00571674 |
| 154 | Menorrhagia (HP:0000132) | 2.00346847 |
| 155 | Renal cortical cysts (HP:0000803) | 2.00043496 |
| 156 | IgG deficiency (HP:0004315) | 1.99066483 |
| 157 | Episodic fever (HP:0001954) | 1.98407845 |
| 158 | Neurofibrillary tangles (HP:0002185) | 1.97447154 |
| 159 | Keratitis (HP:0000491) | 1.97228151 |
| 160 | Eosinophilia (HP:0001880) | 1.91760033 |
| 161 | Colitis (HP:0002583) | 1.90535980 |
| 162 | Granulocytopenia (HP:0001913) | 1.90492104 |
| 163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90275761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.93879150 |
| 2 | TYK2 | 3.84360564 |
| 3 | TBK1 | 3.25068083 |
| 4 | GRK7 | 3.18671469 |
| 5 | FGFR4 | 3.03650641 |
| 6 | IKBKE | 2.88975907 |
| 7 | JAK3 | 2.87470911 |
| 8 | BCKDK | 2.73663486 |
| 9 | JAK1 | 2.70586555 |
| 10 | TAOK2 | 2.66285067 |
| 11 | IKBKB | 2.54325334 |
| 12 | ERN1 | 2.52392860 |
| 13 | PRPF4B | 2.28714392 |
| 14 | MAP3K13 | 2.28193326 |
| 15 | IRAK4 | 2.26379493 |
| 16 | IRAK3 | 2.23671136 |
| 17 | DDR2 | 2.13772409 |
| 18 | KIT | 1.99028736 |
| 19 | BLK | 1.97757634 |
| 20 | SIK1 | 1.86615654 |
| 21 | CHUK | 1.85758605 |
| 22 | FLT3 | 1.85305072 |
| 23 | TAOK3 | 1.80353701 |
| 24 | PIM2 | 1.78164536 |
| 25 | EPHA3 | 1.75940862 |
| 26 | MOS | 1.74872549 |
| 27 | INSRR | 1.69154006 |
| 28 | EPHB1 | 1.68570229 |
| 29 | TXK | 1.67777725 |
| 30 | MAP4K1 | 1.65122149 |
| 31 | NEK9 | 1.60100289 |
| 32 | FGFR3 | 1.46856625 |
| 33 | TAOK1 | 1.46179442 |
| 34 | ZAP70 | 1.42151651 |
| 35 | CDC42BPA | 1.33588567 |
| 36 | PIK3CG | 1.32035083 |
| 37 | PBK | 1.27886125 |
| 38 | FGR | 1.27366584 |
| 39 | JAK2 | 1.27137106 |
| 40 | IRAK1 | 1.20321539 |
| 41 | BTK | 1.17253002 |
| 42 | TEC | 1.11106676 |
| 43 | CSF1R | 1.09527852 |
| 44 | NLK | 1.08663896 |
| 45 | EIF2AK2 | 1.06658617 |
| 46 | MST1R | 1.05223542 |
| 47 | CLK1 | 1.03668054 |
| 48 | BMPR2 | 0.98942917 |
| 49 | RIPK4 | 0.97919593 |
| 50 | MAPK11 | 0.96285070 |
| 51 | CSK | 0.93672906 |
| 52 | PRKAA2 | 0.91817505 |
| 53 | STK10 | 0.90583349 |
| 54 | * SYK | 0.85702147 |
| 55 | MAP2K3 | 0.84218923 |
| 56 | HIPK2 | 0.82531791 |
| 57 | PIM1 | 0.82306532 |
| 58 | TGFBR2 | 0.79454290 |
| 59 | KDR | 0.77420243 |
| 60 | ABL2 | 0.76835628 |
| 61 | RPS6KA4 | 0.76256091 |
| 62 | TESK2 | 0.75826825 |
| 63 | TRPM7 | 0.75787746 |
| 64 | MAPKAPK3 | 0.74321418 |
| 65 | BCR | 0.73666307 |
| 66 | BMPR1B | 0.73198082 |
| 67 | MAP3K3 | 0.72259919 |
| 68 | LCK | 0.71430007 |
| 69 | HCK | 0.71246172 |
| 70 | PTK6 | 0.68890474 |
| 71 | NME2 | 0.67401191 |
| 72 | LYN | 0.67396377 |
| 73 | MAP2K6 | 0.67212132 |
| 74 | TESK1 | 0.66431001 |
| 75 | MYLK | 0.66237443 |
| 76 | MAP3K5 | 0.65989868 |
| 77 | TGFBR1 | 0.65594545 |
| 78 | MUSK | 0.63947969 |
| 79 | SIK3 | 0.63638415 |
| 80 | ERBB4 | 0.62534072 |
| 81 | RIPK1 | 0.61008882 |
| 82 | PIK3CA | 0.60765973 |
| 83 | FES | 0.59607069 |
| 84 | TIE1 | 0.58132815 |
| 85 | PKN2 | 0.57436421 |
| 86 | TRIB3 | 0.54804085 |
| 87 | STK4 | 0.51130517 |
| 88 | CAMK1D | 0.50245772 |
| 89 | MATK | 0.50076528 |
| 90 | PRKCQ | 0.48825759 |
| 91 | MAP3K12 | 0.48223737 |
| 92 | MST4 | 0.47938957 |
| 93 | LATS2 | 0.47491346 |
| 94 | NUAK1 | 0.47332046 |
| 95 | MARK3 | 0.47284973 |
| 96 | PRKCD | 0.45838160 |
| 97 | MAPK12 | 0.44130246 |
| 98 | ARAF | 0.43559515 |
| 99 | MAPK7 | 0.43103550 |
| 100 | MAP3K7 | 0.42495663 |
| 101 | ABL1 | 0.40622408 |
| 102 | MAPK4 | 0.40012088 |
| 103 | MAPKAPK2 | 0.39248582 |
| 104 | PDK1 | 0.38641531 |
| 105 | DAPK3 | 0.38619550 |
| 106 | CDK6 | 0.38436318 |
| 107 | TYRO3 | 0.38104972 |
| 108 | IRAK2 | 0.37535516 |
| 109 | PDGFRA | 0.36633135 |
| 110 | ERBB3 | 0.35450438 |
| 111 | PAK4 | 0.35189505 |
| 112 | PDPK1 | 0.34499775 |
| 113 | ITK | 0.34164527 |
| 114 | PKN1 | 0.33240176 |
| 115 | MAP3K1 | 0.32966976 |
| 116 | RPS6KA6 | 0.31881808 |
| 117 | TTN | 0.31857727 |
| 118 | IGF1R | 0.31403174 |
| 119 | ADRBK2 | 0.31356269 |
| 120 | ACVR1B | 0.30786657 |
| 121 | MAP3K11 | 0.28983186 |
| 122 | OBSCN | 0.28205965 |
| 123 | BMX | 0.28125751 |
| 124 | PRKACG | 0.28013902 |
| 125 | CDK4 | 0.27971206 |
| 126 | FRK | 0.27617048 |
| 127 | STK24 | 0.26719133 |
| 128 | INSR | 0.24113163 |
| 129 | PDGFRB | 0.23390353 |
| 130 | DAPK2 | 0.22392659 |
| 131 | TNK2 | 0.21958041 |
| 132 | RPS6KC1 | 0.20149504 |
| 133 | RPS6KL1 | 0.20149504 |
| 134 | DAPK1 | 0.19384982 |
| 135 | PRKG2 | 0.19045839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.65263533 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47338177 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56607017 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.40171377 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31619151 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.28997648 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27416802 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25058497 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20190002 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17718136 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13727189 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01831341 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91416270 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91225420 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 1.89591278 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80360000 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78040497 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71534756 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64530851 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61506348 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.59173513 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57986136 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.56704317 |
| 24 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56072701 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55738786 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55736528 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.54977262 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51143837 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51005605 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48283423 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47115159 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46397354 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45239093 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44799973 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.39515627 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38204396 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37685356 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30494392 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28318986 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28070382 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.26229385 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25494879 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21837687 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21045920 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17528574 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16025948 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15200593 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.13841013 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12297397 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.09337682 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.07979190 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06609012 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05448801 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02832336 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02793060 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02542149 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02162748 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01187966 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.01050223 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00361294 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96515768 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94597707 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.94152587 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94141421 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.91082065 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90972297 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90308335 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88958930 |
| 69 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88595144 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88506209 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85805287 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.85741021 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85032407 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.84786322 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84722786 |
| 76 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84149320 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83472191 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83118848 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82876938 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.82809744 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80846151 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80588635 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79295551 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78806537 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77849634 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77782549 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77029393 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76665860 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70393854 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69024825 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.68145508 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.67715801 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64881888 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64481784 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64036979 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63361467 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63077526 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.62360595 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62152573 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61149432 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61132319 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61113812 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.60549654 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59922371 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.58230972 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52588933 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52263111 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51883527 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.49980381 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49800619 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49575788 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49463797 |
| 113 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.49462112 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48128577 |
| 115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47449106 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46901360 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45241342 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44474008 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44109015 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42752736 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42244612 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42188186 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39459919 |
| 124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39446404 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38837509 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38343668 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38288375 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37160352 |
| 129 | Lysine degradation_Homo sapiens_hsa00310 | 0.37117204 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.33612242 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32826498 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32808702 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31841879 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30254219 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29766400 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26406447 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26005830 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.25529137 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25282322 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22916237 |
| 141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21772185 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21037621 |
| 143 | Proteasome_Homo sapiens_hsa03050 | 0.18938437 |
| 144 | Platelet activation_Homo sapiens_hsa04611 | 0.16459909 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14149641 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.13291369 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10896106 |
| 148 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10101211 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.09060222 |
| 150 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.09014104 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08214414 |

